Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress

X Wu, J Jiang, Z Gu, J Zhang, Y Chen, X Liu - Stem cell research & …, 2020 - Springer
Mesenchymal stromal cells (MSCs) are a subset of heterogeneous non-hematopoietic
fibroblast-like cells that can differentiate into cells of multiple lineages, such as …

[HTML][HTML] Molecular mimicry and autoimmunity

M Rojas, P Restrepo-Jiménez, DM Monsalve… - Journal of …, 2018 - Elsevier
Molecular mimicry is one of the leading mechanisms by which infectious or chemical agents
may induce autoimmunity. It occurs when similarities between foreign and self-peptides …

Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention

L Zhang, P Qing, H Yang, Y Wu, Y Liu… - Frontiers in …, 2021 - frontiersin.org
Systemic lupus erythematosus (SLE), often considered the prototype of autoimmune
diseases, is characterized by over-activation of the autoimmune system with abnormal …

Hydroxychloroquine in systemic lupus erythematosus (SLE)

C Ponticelli, G Moroni - Expert opinion on drug safety, 2017 - Taylor & Francis
Introduction: Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that
accumulates in lysosomes where it inhibits some important functions by increasing the pH …

Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus

CM Tipton, CF Fucile, J Darce, A Chida, T Ichikawa… - Nature …, 2015 - nature.com
Acute systemic lupus erythematosus (SLE) courses with surges of antibody-secreting cells
(ASCs) whose origin, diversity and contribution to serum autoantibodies remain unknown …

Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity

V Sisirak, B Sally, V d'Agati, W Martinez-Ortiz… - Cell, 2016 - cell.com
Antibodies to DNA and chromatin drive autoimmunity in systemic lupus erythematosus
(SLE). Null mutations and hypomorphic variants of the secreted deoxyribonuclease …

Bystander activation and autoimmunity

Y Pacheco, Y Acosta-Ampudia, DM Monsalve… - Journal of …, 2019 - Elsevier
The interaction over time of genetic, epigenetic and environmental factors (ie, autoimmune
ecology) increases or decreases the liability an individual would have to develop an …

Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification

ME Munroe, R Lu, YD Zhao, DA Fife… - Annals of the …, 2016 - ard.bmj.com
Objectives The relationship of immune dysregulation and autoantibody production that may
contribute to systemic lupus erythematosus (SLE) pathogenesis is unknown. This study …

Telitacicept: first approval

S Dhillon - Drugs, 2021 - Springer
Telitacicept (Tai'ai®) is fusion protein comprising a recombinant transmembrane activator
and calcium modulator and cyclophilin ligand interactor (TACI) receptor fused to the …

Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management

G Fortuna, MT Brennan - Dental Clinics, 2013 - dental.theclinics.com
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder, characterized by
production of autoantibodies directed against nuclear and cytoplasmic antigens, which may …